Find and Pitch Jounalists, Get Your Story Covered

Tags: epistaxis pomalidomide bleeding disorder recurrent von willebrand disease

	Profile	Recent Articles on Subject
1	1387865 PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	NICE nod for Darzalex with lenalidomide and dexamethasone - 12 months ago
2	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer - 4 days ago Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC - 8 days ago Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma - 15 days ago Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies - about 2 months ago Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 2 months ago A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu - 7 months ago Novel Therapy Promising for Radiation-Induced Oral Mucositis - 7 months ago All-Oral Therapy Promising in Higher-Risk MDS, CMML - 8 months ago Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer - 11 months ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - 11 months ago Multi-Agent Treatment Offers Hope in Advanced or Recurrent Endometrial Cancer - 11 months ago
3	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Scotland first in UK to approve new myeloma treatment - 8 days ago
4	John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. Healthcare journalism	Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus - 15 days ago Everything (Maybe) You Wanted to Know About Sarilumab for PMR - 12 months ago
5	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves Amivantamab-Vmjw and Lazertinib for First-Line Treatment of NSCLC - about 1 month ago FDA Grants Priority Review for Asciminib for Chronic Myeloid Leukemia - about 2 months ago Biosimilar Disease-Modifying Antirheumatic Drugs Show Potential Cost Savings for Rheumatoid Arthritis - 2 months ago Luspatercept Reduces Transfusion Burden Compared With Epoetin Alfa - 3 months ago FDA Approves Idecabtagene Vicleucel for Multiple Myeloma After 2 or More Lines of Therapy - 6 months ago Dostarlimab Plus Chemotherapy Demonstrates Significant Overall Survival Benefit in Endometrial Cancer - 6 months ago Biosimilar Candidate GP40141 Found Similar to Romiplostim for Idiopathic Thrombocytopenic Purpura - 10 months ago Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma - 10 months ago FDA Accepts Supplemental Biologics License Application for Hadlima for Interchangeability With Humira - 10 months ago Domvanalimab-Containing Regimen Shows Positive Preliminary Data for Upper Gastrointestinal Cancers - 11 months ago Datopotamab Deruxtecan Demonstrates Improvement in Progression-Free Survival in HR+, HER2- Breast Cancer - 12 months ago
6	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 3 months ago Novel Combination Active in Large B-Cell Lymphoma, Even After CAR-T - 8 months ago Daratumumab Added to Standard Therapy Improves PFS in Multiple Myeloma - 9 months ago Combining Immunotherapy and PARP Inhibition in Advanced Uterine Cancer - 10 months ago Ubamatamab Shows Some Activity in Recurrent Ovarian Cancer - 10 months ago Anti-TIGIT Drug Fails to Lift Response Rates in Cervical Cancer Trial - 10 months ago
7	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	FDA Approves Durvalumab Plus Chemotherapy to Treat Endometrial Cancer - 3 months ago Treatment With Anifrolumab-fnia Shows Promising Rates of Remission for Lupus - 11 months ago
8	Clare Wilson New Scientist Science news source. Worldwide sciencenewstechnology	Polycystic ovary syndrome could be treated with a malaria drug - 3 months ago
9	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	FDA Approves Earlier Use of CAR-T Products for Myeloma - 5 months ago New Monoclonal Authorized to Prevent COVID in Immunocompromised People - 6 months ago FDA Approves New Frontline Regimen for Aggressive ALL - 6 months ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - 9 months ago Pomalidomide Cuts Severe Epistaxis in Genetic Bleeding Disorder - 9 months ago Menin Inhibitor Yields 63% ORR in Heavily Pretreated Acute Leukemia - 9 months ago MRD Tied to Allo-Transplant Benefit in NPM1-Mutated Acute Myeloid Leukemia - 9 months ago Benefits of Myeloma Regimens in the Real World Fall Well Short of Trials - 9 months ago Completely Oral Regimen Effective, Feasible in APL - 9 months ago Lymphoma Drug Copanlisib to Be Pulled From U.S. Market - 10 months ago
10	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Relapsed/Refractory Multiple Myeloma Treatment Advances With Three BiTE Therapy Options - 6 months ago Subcutaneous Daratumumab Plus VRd Significantly Improved PFS, Increased Depth of Response in Patients With Newly Diagnosed Multiple Myeloma - 9 months ago

Journalists covering pomalidomide